Skip to main content

Table 3 Blood glucose, lactate and pyruvate concentrations for each of the three trials.

From: Brain serotonergic and dopaminergic modulators, perceptual responses and endurance exercise performance following caffeine co-ingested with a high fat meal in trained humans

  

Blood collection time (min)

Variables

Trials

Rest

15

30

45

60

75

90

End

[Glucose] (mmol·L-1)

Control

4.9 ± 0.9

3.8 ± 0.4

4.1 ± 0.3

4.2 ± 0.4

4.0 ± 0.4

3.9 ± 0.4

3.9 ± 0.5

4.1 ± 1.0

 

F

4.7 ± 0.6

4.1 ± 0.5

4.4 ± 0.4§

4.3 ± 0.3

4.1 ± 0.3

3.9 ± 0.3

3.8 ± 0.4

3.8 ± 0.4

 

FC

4.7 ± 0.3

4.6 ± 0.4

4.8 ± 0.3*

4.8 ± 0.4*

4.7 ± 0.4*

4.4 ± 0.4*

4.3 ± 0.3*§

4.1 ± 0.5*§

[Lactate] (mmol·L-1)

Control

0.8 ± 0.2

3.6 ± 1.9

3.4 ± 2.1

3.5 ± 2.2

3.6 ± 2.1

3.8 ± 2.4

3.5 ± 1.8

4.5 ± 1.8

 

F

0.8 ± 0.3

3.4 ± 0.9

3.1 ± 1.1

3.0 ± 1.3§

2.9 ± 1.3§

2.9 ± 1.2§

3.1 ± 1.2

4.1 ± 2.0

 

FC

0.8 ± 0.2

4.1 ± 1.5*

4.0 ± 1.8*

3.9 ± 1.9*

3.8 ± 1.9*

3.9 ± 1.9*

3.9 ± 1.8*

5.1 ± 2.1*

[Pyruvate] (μ mol·L-)

Control

157 ± 33

230 ± 46

218 ± 50

221 ± 49

224 ± 51

228 ± 48

234 ± 53

254 ± 61

 

F

159 ± 33

235 ± 49

223 ± 58§

218 ± 53

212 ± 57

215 ± 44

216 ± 47

219 ± 46

 

FC

163 ± 41

256 ± 52

252 ± 58*

250 ± 57*

245 ± 57*

237 ± 63

239 ± 61

234 ± 51

  1. Values are presented as the mean ± SD
  2. *: Indicates a significant difference from the F trial at the same time-point.
  3. §: Indicates a significant difference within the trials compared with the 15 min time-point.